These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

483 related items for PubMed ID: 22877426

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday.
    McClung M, Harris ST, Miller PD, Bauer DC, Davison KS, Dian L, Hanley DA, Kendler DL, Yuen CK, Lewiecki EM.
    Am J Med; 2013 Jan; 126(1):13-20. PubMed ID: 23177553
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. FPIN's clinical inquiries. Risks of bisphosphonate use.
    Scott MA, Meadowcraft L, Skolnik D.
    Am Fam Physician; 2013 Nov 15; 88(10):697, 702. PubMed ID: 24364486
    [No Abstract] [Full Text] [Related]

  • 9. [Is SSBT associated with atypical femoral fracture? SSBT isn't associated with atypical femoral fracture].
    Soen S.
    Clin Calcium; 2012 Jun 15; 22(6):919-22. PubMed ID: 22653034
    [Abstract] [Full Text] [Related]

  • 10. Role of bisphosphonates in the management of postmenopausal osteoporosis: an update on recent safety anxieties.
    Hollick RJ, Reid DM.
    Menopause Int; 2011 Jun 15; 17(2):66-72. PubMed ID: 21693503
    [Abstract] [Full Text] [Related]

  • 11. Bisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays.
    Brown JP, Morin S, Leslie W, Papaioannou A, Cheung AM, Davison KS, Goltzman D, Hanley DA, Hodsman A, Josse R, Jovaisas A, Juby A, Kaiser S, Karaplis A, Kendler D, Khan A, Ngui D, Olszynski W, Ste-Marie LG, Adachi J.
    Can Fam Physician; 2014 Apr 15; 60(4):324-33. PubMed ID: 24733321
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Use of bisphosphonates in older adults: how long is long enough?
    Dunn RL, Bird ML, Conway SE, Stratton MA.
    Consult Pharm; 2013 Jan 15; 28(1):39-57. PubMed ID: 23315281
    [Abstract] [Full Text] [Related]

  • 14. [Is SSBT associated with atypical femoral fracture? SSBT is associated with atypical femoral fracture - pathophysiology of atypical femoral fractures - ].
    Mashiba T.
    Clin Calcium; 2012 Jun 15; 22(6):914-8. PubMed ID: 22653033
    [Abstract] [Full Text] [Related]

  • 15. Use of drug holidays in women taking bisphosphonates.
    Diab DL, Watts NB.
    Menopause; 2014 Feb 15; 21(2):195-7. PubMed ID: 23921518
    [Abstract] [Full Text] [Related]

  • 16. Clinical strategies to address patients' concerns in osteoporosis management with bisphosphonates.
    Cole RE.
    Postgrad Med; 2011 Mar 15; 123(2):131-44. PubMed ID: 21474901
    [Abstract] [Full Text] [Related]

  • 17. What is the optimal duration of bisphosphonate therapy?
    Ott SM.
    Cleve Clin J Med; 2011 Sep 15; 78(9):619-30. PubMed ID: 21885695
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Bisphosphonates in the treatment of osteoporosis: a review of their contribution and controversies.
    Reid IR.
    Skeletal Radiol; 2011 Sep 15; 40(9):1191-6. PubMed ID: 21847749
    [Abstract] [Full Text] [Related]

  • 20. [Calcium pros and cons: long term use of bisphosphonates. Bisphosphonates should be used for postmenopausal osteoporosis for a long term].
    Soen S.
    Clin Calcium; 2011 Oct 15; 21(10):1543-6. PubMed ID: 21960242
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.